El fuerte crecimiento de los ingresos no logra proteger los márgenes de las empresas indias en el trimestre de marzo

Las empresas de la India registraron sólidos aumentos en sus ingresos durante el trimestre de marzo de 2026. Sin embargo, el aumento de los costes de los insumos y una rupia más débil presionaron los márgenes operativos de muchas compañías.

Sectores como el automotriz y el bancario registraron un crecimiento sólido. Por el contrario, las empresas cementeras y petroleras enfrentaron dificultades notables durante el mismo período.

Artículos relacionados

Realistic illustration showing India's economic growth with cityscape and financial symbols amid global challenges.
Imagen generada por IA

India's economy grows 7.7 per cent in 2025-26 amid global shocks

Reportado por IA Imagen generada por IA

Provisional GDP estimates released on Friday show 7.7 per cent growth for 2025-26. The figure exceeds the government's February prediction by 0.1 percentage points. Outlook for 2026-27 points to a slowdown.

Nifty 50 firms expect double-digit revenue growth for the June 2026 quarter but project only single-digit profit increases due to rising costs. Input cost inflation and higher crude prices are squeezing margins across sectors.

Reportado por IA

India's listed brokers and exchanges posted strong results for the March quarter. Growth came from higher margin trading and increased market activity.

Gokaldas Exports achieved strong sequential growth in both revenue and profit for the March quarter. The company posted a 9% rise in revenue despite ongoing global trade disruptions and US tariff pressures.

Reportado por IA

Tata Consultancy Services posted flat dollar revenue for the June quarter along with margin contraction. AI revenue grew but stayed a small share of total earnings. The company also paid out large dividends.

Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.

Reportado por IA

Indian pharmaceutical companies Dr Reddy's and Cipla reported weaker results for the June quarter due to falling profits in the US market. Their domestic operations performed better and provided some offset. Analysts lowered earnings estimates for future years as a result.

 

 

 

Este sitio web utiliza cookies

Utilizamos cookies para análisis con el fin de mejorar nuestro sitio. Lee nuestra política de privacidad para más información.
Rechazar